Hologram Sciences launches personalized vitamin D solution for immune health

Image courtesy of Hologram Sciences

Hologram Sciences (New York City, NY), the consumer-facing company launched by Royal DSM, has released its first direct-to-consumer brand called d.velop. The new brand offers an exclusive form of vitamin D the firm says was scientifically shown¹ to help achieve optimal levels three times faster than conventional vitamin D supplements. In addition to the supplement, the brand also offers a diagnostic kit to test one’s vitamin D levels prior to and two weeks after supplementation, as well as digital support.

“At Hologram, we’re committed to creating and rapidly scaling products that are backed by proven science, pioneering technology, and habit-building,” said Ian Brady, CEO Hologram Sciences, in a press release. “We chose to focus our first brand and product on immunity because we wanted to give people a tool to feel more confident about their health as they step back into the world.”

Consumers shopping d.velop will have a choice of purchasing a single 30-day supply or a three-month supply of the d.velop vitamin D. Access to the free d.velop app will provide users with actionable information to help them understand their immune health more precisely, and then take action. The app will also include access to live coaching from registered dietitians who can answer questions and provide tips for staying on course. The subscription option will provide consumers with the free two-pack vitamin D test, so that they can test their levels before and after taking the supplement.

“No two people are the same and that goes for nutrition as well,” said Melissa Rifkin, MS, RD, CDN, in a press release. “Understanding how to increase one’s immunity is one of the biggest challenges people face and d.velop addresses that challenge in a very personal way. I’m excited to partner with Hologram to share the importance of personalized nutrition and holistic health.”

Reference

1. Quesada-Gomez JM et al. “Is calcifediol better than cholecalciferol for vitamin D supplementation?” Osteoporosis International, vol. 29 (2018): 1697-1711